H-QLVFGIEVV-OH
Ref. 3D-PP46035
1mg | 217,00 € | ||
10mg | 253,00 € | ||
100mg | 455,00 € |
Información del producto
- NH2-Gln-Leu-Val-Phe-Gly-Ile-Glu-Val-Val-OH
Peptide H-QLVFGIEVV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QLVFGIEVV-OH include the following: The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides XM Zhang, YF Zhang, Y Huang, P Qu - Oncology , 2008 - spandidos-publications.comhttps://www.spandidos-publications.com/or/20/1/245 Prediction and analysis of HLA-A2/A24-restricted cytotoxic T-lymphocyte epitopes of the tumor antigen MAGE-n using the artificial neural networks method on XM Zhang, Y Huang, ZS Li, H Lin - Oncology , 2010 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/ol.2010.193 Preparation of a new combination nanoemulsion-encapsulated MAGE1-MAGE3-MAGEn/HSP70 vaccine and study of its immunotherapeutic effect X Zhang, Y Huang, X Li, Y Wang, Y Yuan - Pathology-Research and , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0344033819330766 Identification of HLA-A2-restricted CTL epitope encoded by the MAGE-n gene of human hepatocellular carcinoma HL Dong, ZS Li, J Ye, P Qu , YY Huang - Cancer Biology & , 2004 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/cbt.3.9.1081 Êâ°å޺åâºÂ MAGE-n Ú¡šÀœÂÚâœÀžŜÀºº HSP70 ÚşÂÃ¥ÂËåŞºåâºÂ çšâÊşâ建åŠڡšÚŸŸçº¯åÅâ 匠çhttp://www.cmbp.net.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=8671&sa=U&ved=2ahUKEwjax4HCudrnAhWBUN4KHR0VDIMQFjAGegQIBxAB&usg=AOvVaw2p8m1EypXm5EbeKggRCEM_
Propiedades químicas
Consulta técnica sobre: 3D-PP46035 H-QLVFGIEVV-OH
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.